Filters: Author is Walker, Brian R [Clear All Filters]
11 beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome. Molecular and cellular endocrinology. 2004;215:45-54.
11 beta-hydroxysteroid dehydrogenase type 1 is a predominant 11 beta-reductase in the intact perfused rat liver. The Journal of endocrinology. 2000;165:685-92.
11-Beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitors in type 2 diabetes mellitus and obesity. Expert Opin Investig Drugs. 2008;17(4):481-96.
11Beta-hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics. Proceedings of the National Academy of Sciences of the United States of America. 2004;101:6734-9.
11beta-hydroxysteroid dehydrogenase type 1 as a modulator of glucocorticoid action: from metabolism to memory. Trends in endocrinology and metabolism: TEM. 2004;15:418-24.
11beta-hydroxysteroid dehydrogenase type 1 as a novel therapeutic target in metabolic and neurodegenerative disease. Expert opinion on therapeutic targets. 2003;7:771-83.
11β-hydroxysteroid dehydrogenase type 1, brain atrophy and cognitive decline. Neurobiol Aging. 2010.
5alpha-reduced glucocorticoids, novel endogenous activators of the glucocorticoid receptor. The Journal of biological chemistry. 2004;279:22908-12.
Abnormal cortisol metabolism and tissue sensitivity to cortisol in patients with glucose intolerance. The Journal of clinical endocrinology and metabolism. 2002;87:5587-93.
Activation of the endothelin system in insulin resistance. QJM : monthly journal of the Association of Physicians. 2001;94:321-6.
Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study. Circulation. 2002;106:2659-65.
Altered peripheral sensitivity to glucocorticoids in primary open-angle glaucoma. Investigative ophthalmology & visual science. 2003;44:5163-7.
Altered vascular contractility in adult female rats with hypertension programmed by prenatal glucocorticoid exposure. The Journal of endocrinology. 2006;188:435-42.
Bile acids modulate glucocorticoid metabolism and the hypothalamic-pituitary-adrenal axis in obstructive jaundice. J Hepatol. 2010;52(5):705-11.
Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver. The Journal of clinical endocrinology and metabolism. 2003;88:4924-31.
Combined receptor antagonist stimulation of the hypothalamic-pituitary-adrenal axis test identifies impaired negative feedback sensitivity to cortisol in obese men. J Clin Endocrinol Metab. 2009;94(4):1347-52.
The contribution of visceral adipose tissue to splanchnic cortisol production in healthy humans. Diabetes. 2005;54:1364-70.
Correlation of HO-1 expression with onset and reversal of hypoxia-induced vasoconstrictor hyporeactivity. American journal of physiology. Heart and circulatory physiology. 2001;281:H298-307.
Cortisol inactivation by 11beta-hydroxysteroid dehydrogenase-2 may enhance endometrial angiogenesis via reduced thrombospondin-1 in heavy menstruation. J Clin Endocrinol Metab. 2009;94(4):1443-50.
Cortisol release from adipose tissue by 11beta-hydroxysteroid dehydrogenase type 1 in humans. Diabetes. 2009;58:46-53.
Cortisol secretion and rate of bone loss in a population-based cohort of elderly men and women. Calcified tissue international. 2005;77:134-8.